Sei Investments CO Alector, Inc. Transaction History

Sei Investments CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$6.88 - $9.55 $48,627 - $67,499	-7,068 Reduced 14.49%	41,711 $384,000
Q3 2022 Nov 14, 2022	BUY	$8.19 - $13.2 $399,500 - $643,882	48,779 New	48,779 $461,000
Q1 2022 May 13, 2022	SELL	$13.02 - $20.78 $179,871 - $287,075	-13,815 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$19.35 - $25.54 $32,604 - $43,034	-1,685 Reduced 10.87%	13,815 $285,000
Q3 2021 Nov 12, 2021	BUY	$21.65 - $39.49 $335,575 - $612,095	15,500 New	15,500 $354,000

168

57.8M

146K

90.8K

Ticker ALEC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,563,904
Market Cap $150M
Description
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

Stay updated on Sei Investments CO with notifications on news.